These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Synopsis of vasculitis. When the immune system attacks autologous blood vessels]. Helmke K MMW Fortschr Med; 2000 Mar; 142(13):33-5. PubMed ID: 10783621 [No Abstract] [Full Text] [Related]
4. [Significance of vasculitis in diseases of rheumatic origin]. von Bierbrauer A; Schmidt JA; von Wichert P Internist (Berl); 1993 Jul; 34(7):632-47. PubMed ID: 8365857 [No Abstract] [Full Text] [Related]
5. Hemorrhagic stroke due to cerebral vasculitis and the role of immunosuppressive therapy. Cohen BA; Biller J Neurosurg Clin N Am; 1992 Jul; 3(3):611-24. PubMed ID: 1633484 [TBL] [Abstract][Full Text] [Related]
6. [Rational laboratory diagnosis in clinical immunology and rheumatology]. Saal JG; Dürk H Internist (Berl); 1994 Jul; 35(7):633-9. PubMed ID: 7928165 [No Abstract] [Full Text] [Related]
8. Autoantibodies in systemic rheumatic disorders clinical and diagnostic relevance. Genth E; Mierau R Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):149S-152S. PubMed ID: 9385666 [No Abstract] [Full Text] [Related]
9. Systemic vasculitis: still a long and winding road. Cid MC Curr Opin Rheumatol; 2008 Jan; 20(1):1-2. PubMed ID: 18281849 [No Abstract] [Full Text] [Related]
10. [Immunology in clinical practice IX. Systemic vasculitis]. Kallenberg CG; Tervaert JW Ned Tijdschr Geneeskd; 1998 Jan; 142(3):118-23. PubMed ID: 9557008 [TBL] [Abstract][Full Text] [Related]
11. Current Opinion in Rheumatology. Current world literature. Curr Opin Rheumatol; 2009 Jan; 21(1):85-92. PubMed ID: 19077722 [No Abstract] [Full Text] [Related]
12. [Clinical features and therapy of rheumatic diseases and vasculitides in childhood]. Tenbrock K Hautarzt; 2014 Sep; 65(9):802-9. PubMed ID: 25234629 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis und therapy of ANCA-associated vasculitis]. Aries PM; Hellmich B; Gross WL Dtsch Med Wochenschr; 2006 Mar; 131(9):443-6. PubMed ID: 16493569 [TBL] [Abstract][Full Text] [Related]
14. [Cyclosporin A in inflammatory rheumatic diseases]. Gross WL; Rob PM Internist (Berl); 1996 Jan; 37(1):91-7. PubMed ID: 8837835 [No Abstract] [Full Text] [Related]
15. Potential immunosuppressive therapeutics to target small vessel vasculitis of the kidney. Williams JM Curr Opin Investig Drugs; 2005 Nov; 6(11):1142-8. PubMed ID: 16312136 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary vasculitis: a clinical overview. Hatipoglu U; Rubinstein I Isr Med Assoc J; 2002 Dec; 4(12):1143-8. PubMed ID: 12516912 [No Abstract] [Full Text] [Related]
18. Inhibition of endothelial cell function: should this be a main goal of immunosuppressive strategies? Bach FH J Heart Lung Transplant; 1997 May; 16(5):493-5. PubMed ID: 9171266 [No Abstract] [Full Text] [Related]
19. [ANCA-positive vasculitis of the skin and kidneys associated with acne conglobata]. Manz B; Rytter M; Mittag M; Seidel W; Nenoff P Hautarzt; 2002 Nov; 53(11):730-4. PubMed ID: 12402135 [TBL] [Abstract][Full Text] [Related]
20. [Rheumatic diseases: current technologies and perspectives of laboratory diagnosis]. Nasonov EL; Aleksandrova EN Ter Arkh; 2010; 82(5):5-9. PubMed ID: 20597263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]